Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.22)
# 2,675
Out of 4,876 analysts
205
Total ratings
41.53%
Success rate
-4.32%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| USB U.S. Bancorp | Maintains: In-Line | $44 → $49 | $45.62 | +7.41% | 5 | Jun 4, 2025 | |
| OSUR OraSure Technologies | Maintains: In-Line | $3 | $3.03 | -0.83% | 4 | May 19, 2025 | |
| SYK Stryker | Maintains: Outperform | $400 → $390 | $390.40 | -0.10% | 10 | May 2, 2025 | |
| HOLX Hologic | Maintains: In-Line | $65 → $62 | $65.11 | -4.78% | 14 | May 2, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $60 → $66 | $51.81 | +27.39% | 4 | May 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $96 → $85 | $74.86 | +13.55% | 4 | May 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $19 → $16 | $12.07 | +28.42% | 8 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $585 → $500 | $412.12 | +21.32% | 11 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $110 → $112 | $104.58 | +7.10% | 6 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $510 → $470 | $534.19 | -12.02% | 12 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $75 → $73 | $77.15 | -5.38% | 11 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,450 → $1,475 | $1,193.31 | +23.61% | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $50 → $52 | $30.75 | +69.11% | 6 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $143.28 | +40.98% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $17.10 | +75.44% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $145 → $142 | $119.42 | +18.91% | 3 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $113 → $110 | $91.74 | +19.90% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $354.91 | +0.03% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $36.94 | +51.60% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $96.36 | +66.04% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $86.18 | +20.68% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $32.26 | +79.79% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $201.46 | +37.99% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $169.97 | +70.62% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $133.67 | -7.23% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $30.50 | +47.54% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $13.74 | +96.51% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $94.16 | +85.85% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $98.79 | +26.53% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.73 | +857.33% | 1 | May 31, 2022 |
U.S. Bancorp
Jun 4, 2025
Maintains: In-Line
Price Target: $44 → $49
Current: $45.62
Upside: +7.41%
OraSure Technologies
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $3.03
Upside: -0.83%
Stryker
May 2, 2025
Maintains: Outperform
Price Target: $400 → $390
Current: $390.40
Upside: -0.10%
Hologic
May 2, 2025
Maintains: In-Line
Price Target: $65 → $62
Current: $65.11
Upside: -4.78%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $60 → $66
Current: $51.81
Upside: +27.39%
GE HealthCare Technologies
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $74.86
Upside: +13.55%
Bausch + Lomb
May 1, 2025
Maintains: Outperform
Price Target: $19 → $16
Current: $12.07
Upside: +28.42%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $585 → $500
Current: $412.12
Upside: +21.32%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $104.58
Upside: +7.10%
Intuitive Surgical
Apr 23, 2025
Maintains: In-Line
Price Target: $510 → $470
Current: $534.19
Upside: -12.02%
Feb 12, 2025
Maintains: In-Line
Price Target: $75 → $73
Current: $77.15
Upside: -5.38%
Feb 10, 2025
Maintains: Outperform
Price Target: $1,450 → $1,475
Current: $1,193.31
Upside: +23.61%
Feb 6, 2025
Maintains: In-Line
Price Target: $50 → $52
Current: $30.75
Upside: +69.11%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $143.28
Upside: +40.98%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $17.10
Upside: +75.44%
Nov 26, 2024
Maintains: In-Line
Price Target: $145 → $142
Current: $119.42
Upside: +18.91%
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $91.74
Upside: +19.90%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $354.91
Upside: +0.03%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $36.94
Upside: +51.60%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $96.36
Upside: +66.04%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $86.18
Upside: +20.68%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $32.26
Upside: +79.79%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $201.46
Upside: +37.99%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $169.97
Upside: +70.62%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $133.67
Upside: -7.23%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $30.50
Upside: +47.54%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $13.74
Upside: +96.51%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $94.16
Upside: +85.85%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $98.79
Upside: +26.53%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.73
Upside: +857.33%